Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Corrigendum to "Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states" [Neoplasia 66 (2025) 1101189].
Journal: Neoplasia (New York, N.Y.)
Published: September 07, 2025
A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis.
Journal: American journal of hematology
Published: September 03, 2025
Belantamab mafodotin, pomalidomide, and dexamethasone in Japanese patients with RRMM in the phase 3 DREAMM-8 trial.
Journal: International journal of hematology
Published: August 19, 2025
Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states.
Journal: Neoplasia (New York, N.Y.)
Published: May 19, 2025
Characterizing circulating rare cells in peripheral blood for detecting and monitoring multiple myeloma and precursor states.
Journal: NPJ precision oncology
Published: February 27, 2025
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome.
Journal: Blood cancer journal
Published: July 15, 2024
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: November 10, 2023
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 09, 2023
First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
Journal: Research square
Published: October 04, 2023
Last Updated: 09/26/2026